Drug Name |
Cholic acid |
Drug ID |
BADD_D00453 |
Description |
A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. [PubChem]
Cholic acid, formulated as Cholbam capsules, is approved by the United States Food and Drug Administration as a treatment for children and adults with bile acid synthesis disorders due to single enzyme defects, and for peroxisomal disorders (such as Zellweger syndrome). |
Indications and Usage |
Oral cholic acid is indicated for: treatment of bile acid synthesis disorders due to single enzyme defects; and as adjunctive treatment of peroxisomal disorders including Zellweger spectrum disorders in patients who exhibit manifestations of liver disease, steatorrhea or complications from decreased fat soluble vitamin absorption. |
Marketing Status |
Prescription |
ATC Code |
A05AA03 |
DrugBank ID |
DB02659
|
KEGG ID |
D10699
|
MeSH ID |
D019826
|
PubChem ID |
221493
|
TTD Drug ID |
D0OR2L
|
NDC Product Code |
45043-002; 47049-002; 47049-001; 45043-001 |
Synonyms |
Cholic Acid | Cholbam |